Corvex, Inc. announced on October 14, 2026, that it has entered into an At-the-Market Sales Agreement with Chardan Capital Markets LLC. Under this agreement, the company may offer and sell, from time to time, shares of its common stock through the agent.
The agreement allows Chardan Capital Markets to sell the shares by any method permitted by law and deemed to be an “at the market offering” as defined in Rule 415(a)(4) of the Securities Act of 1933. The company is not obligated to sell any shares under this agreement and may suspend solicitation and offers at any time.
Corvex will pay the agent a commission of 2.5% of the aggregate gross proceeds from sales of shares under the offering. Additionally, the company will reimburse the agent for legal fees and disbursements, including up to $75,000 for the execution of the agreement, up to $10,000 per calendar quarter for representation dates, and up to $30,000 for each program “refresh,” such as the filing of a registration statement or prospectus supplement.
The company intends to use the net proceeds from the offering for working capital and general corporate purposes. The shares are being offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-298769), which was declared effective by the SEC on September 16, 2026.
